Skip to content
Triangle logo TriangleGet started
← Childhood Acute Myeloid Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Postremission Therapy for AML

Source: Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Childhood AML

A major challenge in the treatment of children with AML is to prolong the duration of the initial remission with additional chemotherapy or HSCT.

Treatment options for children with AML in postremission may include the following:

Chemotherapy.

Source links and citations

HSCT.

Source links and citations

Targeted therapy (e.g., FLT3 inhibitors).[59] For more information, see the Induction Therapy section.

Source links and citations

Continue within this section

Chemotherapy →HSCT →

Preserved source evidence · Not medical advice